New York, March 25: Queen’s University cancer researcher Madhuri Koti has discovered a biomarker that will help lead to better predictions of the success of chemotherapy in ovarian cancer patients.
Biomarkers are an indicator of a biological state or condition, and the discovery could lead to better treatment options in the fight against ovarian cancer, according to a press release from the university. “Recent successes in harnessing the immune system to combat cancer are evidence for the significant roles of a cancer patient’s immune responses in fighting cancer,” explains Indian American professor Dr. Koti. “Many of these successes are based on boosting anti-cancer immunity via different therapies. Such therapies would prove to be most effective when coupled with markers predicting a patient’s eventual response to a specific therapy”. Dr. Koti’s study, conducted on over 200 ovarian cancer patients, utilised a combition of cutting-edge detection technologies for identifying such markers. (IANS)